Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors.

نویسندگان

  • P Grossi
  • S Kusne
  • C Rinaldo
  • K St George
  • M Magnone
  • J Rakela
  • J Fung
  • T E Starzl
چکیده

Cytomegalovirus (CMV*), the first reported transplantassociated opportunistic virus (1), has remained the most frequent single cause or co-cause ofinfections throughout the ensuing three decades (2). Because prophylactic drug and hyperimmune globulin therapy has not been effective in these CMV-infected patients (2-4), Rubin (5) suggested withholding treatment until the phase of rapid viral replication (preemptive therapy). Early diagnosis of CMV infection, upon which this strategy depends, can be accomplished in the presymptomatic phase (6, 7) with a rapid quantitative direct demonstration of CMV antigen pp65 in cytospin preparations of peripheral blood leukocytes (PBL) (8, 9). This method has aided in the management of 20 CMV seronegative recipients of livers from seropositive donors, a circumstance that carries an 85-90% risk of virus transmission of CMV disease, presumably from migratory monocytes from the graft (10) that are known to harbor the latent virus in healthy seropositive individuals (1]). The 20 recipients under tacrolimus/prednisone immunosuppression were followed for 308± 100.5 days (range, 63-520 days) after transplantation; a death at 63 days unrelated to CMV accounted for the only follow-up of <3 months. Heparinized blood samples were obtained by schedule during the first 3 months or when clinically indicated during this period and later. The pp65 antigen was detected in duplicate leukocyte spots (2X 105 cells in 200 J.l.lIglass slide) with the tech· nique of Van der Bij et a1. (8), using immunofluorescence (2) instead of immunoperoxidase staining (9). The anti·pp65 mouse monoclonal antibody was clone 1C3 (Hiosoft, Argene, France). Fluorescein·isothiocyanate-Iabeled goat anti·mouse Fab2 fragment (Cappel, Durham, NC) was applied as the conjugate. Slides were counterstained with Evans blue dye and observed under 400 x magnification for the typical green nuclear fluorescence. /\. conventional shell vial culture assay was done on the same blood specimens. Anti·CMV antibodies (lgG and IgM)

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Cytomegalovirus infection in renal transplant recipients.

We have retrospectively analyzed the incidence of cytomegalovirus (CMV) infection in 250 consecutive renal allograft transplants performed in 244 recipients. The mean follow-up was 35.1+/-25.4 months. Immunosuppression was cyclosporine- or tacrolimus-based triple therapy. CMV infection prophylaxis with ganciclovir for 3 months post transplant was prescribed in CMV-seronegative recipients of all...

متن کامل

Effect of high-dose acyclovir on survival in allogeneic marrow transplant recipients who received ganciclovir at engraftment or for cytomegalovirus pp65 antigenemia.

This study sought to determine whether high-dose acyclovir improves posttransplant survival in cytomegalovirus (CMV)-seropositive patients when ganciclovir is given for prophylaxis or as early therapy. Three groups were studied: Group 1 (n = 112) received ganciclovir from engraftment without prior acyclovir treatment, group 2 (n = 114) was given ganciclovir for CMV pp65 antigenemia without prio...

متن کامل

Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation.

In a prospective study, the cytomegalovirus (CMV) pp65 antigenemia assay was compared with detection of CMV by blood culture in 67 consecutive CMV-seropositive patients undergoing autologous marrow or peripheral blood stem cell transplantation. Antigenemia occurred in 26 patients (38.8%) a median of 33 days (range, 12-74) after transplant. Viremia was detected in 5 patients (7.5%) a median of 3...

متن کامل

Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients.

We have previously reported that an intermittent pp65 antigenemiaguided early treatment strategy based on quantitative antigenemia was less effective in preventing cytomegalovirus (CMV) disease before day 100 than ganciclovir administered from engraftment until day 100 (ie, 14.1% v 2.7%, P 5 .002).1 We hypothesized that the high incidence of CMV disease before day 100 in the antigenemia-gancicl...

متن کامل

Lack of emergence of cytomegalovirus UL97 mutations conferring ganciclovir (GCV) resistance following preemptive GCV therapy in allogeneic stem cell transplant recipients.

Fifty allogeneic stem cell transplant recipients were enrolled in a prospective cytomegalovirus pp65 antigenemia-guided preemptive therapy trial. Among these, 10 of 34 patients who received ganciclovir exhibited sustained and/or recurrent antigenemia despite treatment. Thirteen leukocyte preparations from these 10 subjects were screened for the presence of the most frequent cytomegalovirus UL97...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Transplantation

دوره 61 11  شماره 

صفحات  -

تاریخ انتشار 1996